Meet Rocket Lab’s Peter Beck, the Self-Taught Engineer Going Head-to-Head With Elon Musk and Jeff Bezos The Wall Street Journal Peter Beck discusses Neutron development as maiden flight nears NASASpaceFlight.com – Rocket Lab expands Virginia’s role in commercial space launch, exploration The Virginian-Pilot The self-taught engineer going head-to-head with Elon Musk and Jeff Bezos Mint Source link
Read More »Tag Archives: headtohead
Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial – Eli Lilly and Company
Lilly’s oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial Eli Lilly and Company Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial CNBC Daily weight loss pill can help cut body weight by a fifth, trial shows The Guardian Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say Bloomberg.com Lilly weight-loss pill could be FDA-approved by year-end Reuters Source …
Read More »AEW went head-to-head with NJPW at Forbidden Door 2025 — and WWE was the big loser
AEW continued its winning run with another solid pay-per-view as AEW Forbidden Door 2025 came to London’s O2 Arena for the first time on Sunday — wrapping up with a chaotic, Stampede-style match that managed to honor local hero Will Ospreay and the departing Hiroshi Tanahashi while still offering plenty of gasps along the way. As good as the show …
Read More »Narendra Modi and Donald Trump go head-to-head
On August 4th Donald Trump took to Truth Social, his social-media platform, to berate India: because the country’s “massive” oil purchases fund “the Russian War Machine”, he said, it would suffer substantially steeper tariffs than the 25% the president slapped on the country last week. In some ways the president is not wrong: Russia supplied a negligible 0.2% of India’s …
Read More »Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease – Eli Lilly and Company
Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity CNBC Eli Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment statnews.com Eli Lilly Weight-Loss Drug Mounjaro …
Read More »